To elucidate the impact of FCN3 on Wnt/β-catenin signaling and HCC cells, FCN3-overexpressing Hep3B cells were treated with or without the β-catenin activator LY2090314. The gene discussed is FCN3; the disease is hepatocellular carcinoma.